Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
Nessrine Bellamri(Inserm), Laurent Vernhet(Inserm)
Cited by 63
Related Papers
Inorganic Arsenic Activates Reduced NADPH Oxidase in Human Primary Macrophages through a Rho Kinase/p38 Kinase Pathway
|The Journal of Immunology|2008|71
Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis
|International Immunopharmacology|2023|26
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
|Pulmonary Pharmacology & Therapeutics|2023|14
Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
|Toxicology and Applied Pharmacology|2022|12
Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
|The Journal of Nutritional Biochemistry|2024|7